MicroRNA: Crucial modulator in purinergic signalling involved diseases

Area of Science:

• Biochemistry and Molecular Biology
• Physiology
• Pathology

Background:

• MicroRNAs (miRNAs) and purinergic signaling are crucial regulators in diverse physiological and pathological processes.
• Both systems exhibit broad tissue expression across organisms.
• Their interplay is implicated in numerous diseases.

Purpose of the Study:

• To review and synthesize current literature on the relationship between miRNAs and purinergic signaling in specific disease contexts.
• To elucidate the complex network connecting miRNAs and purinergic signaling pathways in disease.
• To identify key miRNAs and purinergic components involved in disease pathogenesis.

Main Methods:

• Comprehensive literature review of publications on miRNAs, purinergic signaling, and diseases.
• Analysis of identified studies to map interactions between specific miRNAs and purinergic receptors/enzymes.
• Identification of common miRNA regulators for key purinergic targets.

Main Results:

• Over 30 miRNAs were found to modulate P1 and P2 receptors and ecto-enzymes involved in purinergic signaling.
• Specific miRNAs target multiple purinergic receptors and ecto-enzymes, including P2X7 and CD73.
• miR-187 was identified as a common regulator for both P2X7 and CD73.

Conclusions:

• A complex regulatory network exists between miRNAs and purinergic signaling in various diseases.
• Targeting specific miRNAs offers potential therapeutic strategies for diseases involving purinergic signaling dysregulation.
• Further research is warranted to fully understand and exploit this miRNA-purinergic signaling axis for therapeutic benefit.